The Latest in Psoriatic Arthritis ICYMI

Study offers reassuring data on certolizumab use in pregnancy

November 10, 2016

Psoriatic Arthritis

What good are biosimilars if patients won’t use them?

November 5, 2016

Psoriatic Arthritis

FDA’s Woodcock: Give biosimilars a chance

November 5, 2016

Psoriatic Arthritis

Biosimilars face barriers to broader acceptance

November 4, 2016

Psoriatic Arthritis

Close monitoring of psoriasis patients can delay PsA onset

November 2, 2016

Psoriatic Arthritis

PsA bone loss measurement: A surrogate for radiographic progression?

November 1, 2016

Psoriatic Arthritis

Tildrakizumab for psoriasis scores high marks in phase III

October 19, 2016

Psoriatic Arthritis

Secukinumab for psoriasis at 4 years: undiminished efficacy and safety

October 18, 2016

Psoriatic Arthritis

Surgical Risks From Systemic Psoriasis Therapies

October 13, 2016

Psoriatic Arthritis

Guselkumab achieves highest-ever response rates in psoriasis

October 12, 2016

Psoriatic Arthritis

Birth outcomes unaffected by paternal immunosuppressive therapy

October 12, 2016

Psoriatic Arthritis

Severe joint pain in adults with arthritis continues to rise

October 11, 2016

Psoriatic Arthritis

Most children with JIA get different diagnosis as adults

October 4, 2016

Psoriatic Arthritis

Psoriasis not consistently linked to adverse pregnancy outcomes

October 3, 2016

Psoriatic Arthritis

FDA approves biosimilar adalimumab

September 27, 2016

Psoriatic Arthritis